België -
Nederlands -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
hansamedic warmtepleister pleister sachet
beiersdorf ag - capsicum annuum l., vrucht, extract, etoh, 80 % 112 mg - 167 mg - pleister - capsicum, vrucht, extract 139.5 mg - capsaicin and similar agents
Nederland -
Nederlands -
CBG-MEB (College ter Beoordeling van Geneesmiddelen)
a.vogel famosan tabletten
biohorma b.v. industriestraat 5 8081 hh elburg - ambra grisea d4 ; cimicifuga racemosa d6 ; lachesis mutus d12 ; sanguinaria canadensis d12 ; sepia officinalis d6 ; zincum metallicum d8 - tablet - , , , , , , , , , , , , , , , , , , - datum verstrekking handelsvergunning:19 november 2002
Nederland -
Nederlands -
CBG-MEB (College ter Beoordeling van Geneesmiddelen)
a. vogel famosan salvia, tabletten
a.vogel b.v. j.p. broekhovenstraat 16 8081 hc elburg - salviae folium (ln) 795 - 1340 mg/stuk - tablet - , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - datum verstrekking handelsvergunning:07 januari 2014
Nederland -
Nederlands -
CBG-MEB (College ter Beoordeling van Geneesmiddelen)
a.vogel famosan druppels
a.vogel b.v. j.p. broekhovenstraat 16 8081 hc elburg - ambra grisea d4 ; cimicifuga racemosa d6 ; lachesis mutus d12 ; sanguinaria canadensis d12 ; sepia officinalis d6 ; zincum metallicum d8 - druppels voor oraal gebruik, oplossing - , , , , , , , , , , , , , , , , , , , , , , - datum verstrekking handelsvergunning:19 november 2002
België -
Nederlands -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
konakion 10 mg/1 ml or. opl./inj. opl. i.m./i.v. amp.
cheplapharm arzneimittel gmbh - fytomenadion 10 mg/ml - oplossing voor injectie; drank - 10 mg/1 ml - fytomenadion 10 mg/ml - phytomenadione
België -
Nederlands -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
konakion paediatric 2 mg/0,2 ml or. opl./inj. opl. i.m./i.v. amp.
cheplapharm arzneimittel gmbh - fytomenadion 2 mg/0,2 ml - oplossing voor injectie; drank - 2 mg/0,2 ml - fytomenadion 10 mg/ml - phytomenadione
Europese Unie -
Nederlands -
EMA (European Medicines Agency)
heplisav b
dynavax gmbh - hepatitis b-oppervlakte-antigeen - hepatitis b - vaccins - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.
Europese Unie -
Nederlands -
EMA (European Medicines Agency)
idefirix
hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunosuppressiva - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.